 OncoCyte Corp NYSEAMERICAN:OCX Piper Sandler issued their Q2 2020 earnings per share EPS estimates for OncoCyte in a research report issued to clients and investors on Wednesday, June 24th. Piper Sandler analyst S. Mah expects that the biotechnology company will earn 0.11 per share for the quarter. Piper Sandler has a Overweight rating and ... 